Introduction Within the SEER database (2010–2021), we tested for differences in cancer-specific mortality (CSM) between partial (PN) vs. radical (RN) nephrectomy in patients with pT3a renal cell carcinoma with either perinephric fat invasion (PFI) or sinus fat invasion (SFI). Patients and Methods Separate propensity score matching (PSM), multivariable competing risk regression (mCRR) analyses and cumulative incidence plots addressed CSM in patients with PFI and subsequently in patients with SFI, according to PN vs. RN. Subgroup analyses focused on patients with additional adverse pathological features: tumor size '4 cm, high nuclear grade or sarcomatoid dedifferentiation. Results Of 9,664 pT3aN0M0 RCC patients with fat invasion, 4379 (45.3%) had exclusive PFI vs. 4398 (45.5%) had exclusive SFI. In PFI patients, 1,321 (30.2%) patients underwent PN vs. 3,058 (69.8%) RN. After 1:1 PSM, 5-years CSM rates were 8.2 vs. 9.3% in PN vs. RN patients. In mCRR, PN vs. RN did not affect CSM (HR 0.99, P = 0.9), even in patients with additional adverse pathological features. In SFI patients, 395 (9.0%) patients underwent PN vs. 4003 (91.0%) RN. After 1:3 PSM, 5-years CSM rates were 7.5 vs. 10.3% in PN vs. RN patients. In mCRR, PN vs. RN did not affect CSM (HR 0.74, P = 0.2), even in patients with additional adverse pathological features. Conclusion PN does not predispose patients to a survival disadvantage in presence of either PFI or SFI, even in those with additional adverse pathological features defined as tumor size '4 cm, high nuclear grade or sarcomatoid dedifferentiation.

Partial vs. radical nephrectomy in pT3a renal cancer: Cancer-specific mortality according to fat invasion pattern

Palumbo, Carlotta;Volpe, Alessandro;
2025-01-01

Abstract

Introduction Within the SEER database (2010–2021), we tested for differences in cancer-specific mortality (CSM) between partial (PN) vs. radical (RN) nephrectomy in patients with pT3a renal cell carcinoma with either perinephric fat invasion (PFI) or sinus fat invasion (SFI). Patients and Methods Separate propensity score matching (PSM), multivariable competing risk regression (mCRR) analyses and cumulative incidence plots addressed CSM in patients with PFI and subsequently in patients with SFI, according to PN vs. RN. Subgroup analyses focused on patients with additional adverse pathological features: tumor size '4 cm, high nuclear grade or sarcomatoid dedifferentiation. Results Of 9,664 pT3aN0M0 RCC patients with fat invasion, 4379 (45.3%) had exclusive PFI vs. 4398 (45.5%) had exclusive SFI. In PFI patients, 1,321 (30.2%) patients underwent PN vs. 3,058 (69.8%) RN. After 1:1 PSM, 5-years CSM rates were 8.2 vs. 9.3% in PN vs. RN patients. In mCRR, PN vs. RN did not affect CSM (HR 0.99, P = 0.9), even in patients with additional adverse pathological features. In SFI patients, 395 (9.0%) patients underwent PN vs. 4003 (91.0%) RN. After 1:3 PSM, 5-years CSM rates were 7.5 vs. 10.3% in PN vs. RN patients. In mCRR, PN vs. RN did not affect CSM (HR 0.74, P = 0.2), even in patients with additional adverse pathological features. Conclusion PN does not predispose patients to a survival disadvantage in presence of either PFI or SFI, even in those with additional adverse pathological features defined as tumor size '4 cm, high nuclear grade or sarcomatoid dedifferentiation.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11579/223230
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact